Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Regado Biosciences Inc Announces Closing of Initial Public Offering


Tuesday, 27 Aug 2013 04:47pm EDT 

Regado Biosciences Inc announced the closing of its previously announced initial public offering of 10,750,000 shares of common stock, at a public offering price of $4.00 per share, resulting in gross proceeds of $43,000,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences. All of the common stock was offered by Regado Biosciences. The company's common stock is listed on The NASDAQ Capital Market under the trading symbol "RGDO." Cowen and Company, LLC and BMO Capital Markets Corp. acted as joint book-running managers for the offering. Canaccord Genuity Inc., Needham & Company, LLC, and Wedbush PacGrow Life Sciences acted as co-managers. 

Company Quote

2.8
0.1 +3.70%
4:00pm EDT